The common cause of elevated GLTA is chronic viral hepatitis, and some patients have fatty liver or alcoholic hepatitis or even cirrhosis from years of alcohol consumption. A persistent increase in transaminases can affect liver function, and in severe cases can also affect the metabolism of fat in the liver, and even affect the blood clotting mechanism, resulting in easy bleeding or hematoma formation, and liver failure. Therefore, if a significant increase in transaminases is detected, liver-protective drugs should be applied in a timely manner, such as compound glycyrrhetinic acid glycoside or compound dichloroacetate diisopropylamine injection. At the same time, we should actively correct the primary disease, systemic antiviral treatment, stay away from smoking and alcohol, eat a reasonable diet, increase the calorie content of food and high protein food or vitamin-rich food, and regularly review biochemical indicators.